Cannell Capital GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 22 filers reported holding GAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Cannell Capital ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$38,721
+96702.5%
12,3710.0%0.01%
-11.1%
Q3 2022$40
+300.0%
12,371
+349.7%
0.01%
+350.0%
Q2 2022$102,7510.00%